当前位置: 首页 > 详情页

Angiotensin II Silencing Alleviates Erectile Dysfunction Through Down-Regulating the Rhoa/Rho Kinase Signaling Pathway in Rats with Diabetes Mellitus

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun, [b]Department of Nephrology, Xuanwu Hospital, Capital Medical University, Beijing, [c]Department of Neurology, First Hospital of Jilin University, Changchun, [d]Department of Vascular Surgery, Jilin Provincial People’s Hospital, Changchun, [e]Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, China
出处:
ISSN:

关键词: Angii RhoA/Rho kinase signaling pathway Diabetes mellitus Erectile dysfunction

摘要:
Background/Aims: We aim to explore the role of angiotensin (Ang) II and the RhoA/Rho kinase signaling pathway in the pathogenesis of erectile dysfunction in diabetes mellitus (DM). Methods: Male Sprague-Dawley (SD) rats were used for experiments and short hairpin RNA (shRNA) was used to silence the AngII gene. The erectile function of rats was observed and intracavernous pressure and mean arterial pressure (ICP/MAP) were measured after electrical stimulation. Relaxation and contraction of smooth muscle in the corpus cavernosum were tested. Western blotting and quantitative RT-PCR were applied to measure the expressions of RhoA, Rho-associated kinase (ROCK) 1 and ROCK2. Radioimmunoassay was applied to detect the levels of AngII. Results: Rats in the control group had the most erectile times, followed by AngII-silenced rats with DMED and rats with DMED. Rats with DMED had worse ICP and MAP than AngII-silenced rats. The contraction ability was markedly improved and relaxation ability was decreased in AngII-silenced rats with DMED as compared with rats with DMED. The levels of AngII were significantly increased in DMED rats while significantly decreased after AngII silencing. The mRNA and proteins of RhoA and ROCK2 were expressed in a similar way. Conclusion: AngII silencing improves erectile dysfunction via down-regulating the RhoA/Rho kinase signaling pathway. (C) 2018 The Author(s) Published by S. Karger AG, Basel

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 生物
小类 | 2 区 生理学 3 区 细胞生物学
最新[2025]版:
大类 | 4 区 生物学
小类 | 4 区 细胞生物学 4 区 生理学
JCR分区:
出版当年[2016]版:
Q1 PHYSIOLOGY Q2 CELL BIOLOGY
最新[2023]版:
Q2 PHYSIOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [a]Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun,
通讯作者:
通讯机构: [*1]Department of Urology, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun 130033, Jilin Province (China)
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17441 今日访问量:0 总访问量:934 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院